High expression of CD134 (over 99%) was maintained over 40 passages of the CLL-CD134 cell line; the cells are IL-2 independent, easily manipulated and robust with a high growth rate compared to MYA-1. Here, TNFRSF4 is linked to B-cell chronic lymphocytic leukemia.